Diagnostic performance of contrast-enhanced ultrasound and enhanced magnetic resonance for breast nodules

Abstract

In the current study, we sought to evaluate the diagnostic efficacies of conventional ultrasound (US), contrast-enhanced US (CEUS), combined US and CEUS and magnetic resonance imaging (MRI) in detecting focal solid breast lesions. Totally 117 patients with 120 BI-RADS category 4A-5 breast lesions were evaluated by conventional US and CEUS, and MRI, respectively. SonoVue was used as contrast agent in CEUS and injected as an intravenous bolus; nodule scan was performed 4 minutes after bolus injection. A specific sonographic quantification software was used to obtain color-coded maps of perfusion parameters for the investigated lesion, namely the time-intensity curve. The pattern of contrast enhancement and related indexes regarding the time-intensity curve were used to describe the lesions, comparatively with pathological results. Histopathologic examination revealed 46 benign and 74 malignant lesions. Sensitivity, specificity, and accuracy of US in detecting malignant breast lesions were 90.14%, 95.92%, and 92.52%, respectively. Meanwhile, CE-MRI showed sensitivity, specificity, and accuracy of 88.73%, 95.92%, and 91.67%, respectively. The area under the ROC curve for combined US and CEUS in discriminating benign from malignant breast lesions was 0.936, while that of MRI was 0.923, with no significant difference between them, as well as among groups. The time-intensity curve of malignant hypervascular fibroadenoma and papillary lesions mostly showed a fast-in/fast-out pattern, with no good correlation between them (kappa<0.20). In conclusion, the combined use of conventional US and CEUS displays good agreement with MRI in differentiating benign from malignant breast lesions.

Keywords

conventional ultrasound / contrast-enhanced ultrasound / breast lesions / BI-RADS / magnetic resonance imaging (MRI) / time–intensity curve (TIC) / contrast-enhanced magnetic resonance imaging (CE-MRI)

References

[1] Less JR, Skalak TC, Sevick EM, Microvascular architecture in a mammary carcinoma: branching patterns and vessel dimensions[J]. Cancer Res, 1991, 51(1): 265–273.

[2] Sehgal CM, Weinstein SP, Arger PH, A review of breast ultrasound[J]. J Mammary Gland Biol Neoplasia, 2006, 11(2): 113–123.

[3] Du J, Li FH, Fang H, Microvascular architecture of breast lesions: evaluation with contrast-enhanced ultrasonographic micro flow imaging[J]. J Ultrasound Med, 2008, 27(6): 833–842., quiz 844.

[4] Du J, Wang L, Wan CF, Differentiating benign from malignant solid breast lesions: combined utility of conventional ultrasound and contrast-enhanced ultrasound in comparison with magnetic resonance imaging[J]. Eur J Radiol, 2012, 81(12): 3890–3899.

[5] Zhao H, Xu R, Ouyang Q, Contrast-enhanced ultrasound is helpful in the differentiation of malignant and benign breast lesions[J]. Eur J Radiol, 2010, 73(2): 288–293.

[6] Liu H, Jiang YX, Liu JB, Evaluation of breast lesions with contrast-enhanced ultrasound using the microvascular imaging technique: initial observations[J]. Breast, 2008, 17(5): 532–539.

[7] Xiao X, Qu B, Yang H, Breast contrast-enhanced ultrasound: is a scoring system feasible?a preliminary study in China[J]. PLoS One, 2014, 9(8): 1–11.

[8] Miyamoto Y, Ito T, Takada E, Efficacy of sonazoid (perflubutane) for contrast-enhanced ultrasound in the differentiation of focal breast lesions: phase 3 multicenter clinical trial[J], AJR Am J Roentgenol, 2014, 202(4): W400–407.

[9] Costantini M, Belli P, Lombardi R, Characterization of solid breast masses: use of the sonographic breast imaging reporting and data system lexicon[J]. J Ultrasound Med, 2006, 25(5): 649–659., quiz 661.

[10] Caproni N, Marchisio F, Pecchi A, Contrast-enhanced ultrasound in the characterisation of breast masses: utility of quantitative analysis in comparison with MRI[J]. Eur Radiol, 2010, 20(6): 1384–1395.

[11] Ricci P, Cantisani V, Ballesio L, Benign and malignant breast lesions: efficacy of real time contrast-enhanced ultrasound vs. magnetic resonance imaging[J]. Ultraschall Med, 2007, 28(1): 57–62.

[12] Strobel K, Schrading S, Hansen NL, Assessment of BI-RADS category 4 lesions detected with screening mammography and screening US: utility of MR imaging[J]. Radiology, 2015, 274(2): 343–351.

[13] Gong XY, Ding HY. Mammary pathology[M]. First edition, Beijing: People’s Medical Publishing House Co., LTD, 2010.

[14] Xiao XY, Hui Z, Yang HY, Comprehensive ultrasonic diagnosis of breast radial scar[J]. Chin J Med Imaging Technol, 2012, 28(11): 2011–2014.

[15] Xia HS, Wang X, Ding H, Papillary breast lesions on contrast-enhanced ultrasound: morphological enhancement patterns and diagnostic strategy[J]. Eur Radiol, 2014, 24(12): 3178–3190.

[16] Linda A, Zuiani C, Londero V, Magnetic resonance imaging of radial sclerosing lesions (radial scars) of the breast[J]. Eur J Radiol, 2012, 81(11): 3201–3207.

[17] Peters NH, Borel Rinkes IH, Zuithoff NP, Meta-analysis of MR imaging in the diagnosis of breast lesions[J]. Radiology, 2008, 246(1): 116–124.

[18] Yeh ED. Characterization of breast lesions with proton MR spectroscopy[J]. AJR Am J Roentgenol, 2003, 181(5): 1273–1274.

[19] Orel SG, Schnall MD. MR imaging of the breast for the detection, diagnosis, and staging of breast cancer[J]. Radiology, 2001, 220(1): 13–30.

[20] Alamo L, Fischer U. Contrast-enhanced color Doppler ultrasound characteristics in hypervascular breast tumors: comparison with MRI[J]. Eur Radiol, 2001, 11(6): 970–977.

[21] Reinikainen H, Pääkkö E, Suramo I, Dynamics of contrast enhancement in MR imaging and power doppler ultrasonography of solid breast lesions[J]. Acta Radiol, 2002, 43: 492–500.

[22] Li XK, Ying Z, Liu PF, Enhancement characterization of breast masses of contrast-enhanced ultrasound: comparison with MRI[J]. Chin J Ultrasonogr, 2014, 23(1): 44–48.

Acknowledgments

This research was supported by the Natural Science Foundation of Jiangsu University (14KJB320003). Our thanks go to professor Yanni Jiang, Department of Radiology, Cong Wang, Department of Pathology, for their assistance in this research. We would like to thank the referees for their comments that helped us improve the manuscript.

RIGHTS & PERMISSIONS

2018 2018 by the Journal of Biomedical Research.